References

  1. Facing the facts: the impact of chronic disease in Africa. 2005. Genève, Organisation mondiale de la Santé. http://www.who.int/chp/chronic_disease_report/media/AFRO.pdf. Accessed 9th November, 2013.

  2. Murray CJL, Lopez AD. The global burden of disease. A comprehensive assessment of mortality and disability from diseases, injures, and risk factors in 1990 and projected to 2020. 1996. Boston. Harvard University Press. Google Scholar

  3. Anderson K, Castelli W, Levy D. Cholesterol and mortality. 30 years of follow-up from the Framingham study. JAMA. 1987; 257(16):2176-2180. PubMed | Google Scholar

  4. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18(6):499-502. PubMed | Google Scholar

  5. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001; 285(19):2486-97. PubMed | Google Scholar

  6. Ndiaye S, Ayad M. Enquête démographique et de santé au Sénégal (EDSIV), Ministère de la santé et de la Prévention Médicale. 2005. Sénégal: Dakar. Centre de recherche pour le développement Humain. PubMed | Google Scholar

  7. Tiahou G, Deret K, Monde A. Fréquence des bilans lipidiques et prévalence des dyslipidémies au laboratoire de Biochimie du CHU de Cocody. Jsci pharm Biol. 2010. 11(2):60-65. PubMed | Google Scholar

  8. Agence Nationale de la Statistique et de la Démographie (ANSD). Situation Economique et Sociale du Sénégal 2008. 2009. Senegal: Dakar. ANSD. Google Scholar

  9. Essais O, Jabrane J, Bouguerra R, El Atti J, et al. Distribution et prévalence des dyslipidémies en Tunisie: Résultats de l'enquète nationale de nutrition. La Tunisie Medicale. 2009; 87(8):505- 510. PubMed | Google Scholar

  10. Khader YS, Batieha A, El-Khateeb M, Al Omari M, Ajlouni K. Prevalence of dyslipidemia and its associated factors among Jordanian adults. Journal of Clinical Lipidology. 2010; 4(1):53-58. PubMed | Google Scholar

  11. Pessinaba S, Mbaye A, Yabéta GAD, Harouna H, et al. Enquête de prévalence des facteurs de risque cardiovasculaire en population générale à Saint-Louis (Sénégal). Ann Cardiol Angeiol. 2013; 62(4): 253-258. PubMed | Google Scholar

  12. Erem C, Hacihasanoglu A, Deger O, Kocak M, Topbas M. Prevalence of dyslipidemias and associated risk factors among Turkish adults: Trabzon Lipid Study. Endocrine. 2008; 34(1-3):36-51. PubMed | Google Scholar

  13. Zahid N, Claussen B, Hussain A. High prevalence of obesity, dyslipidemias and metabolic syndrome in a rural area in Pakistan. Diabetes Metabol Syndr. 2008; 2(1):13-19. PubMed | Google Scholar